Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy

Development and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy

The present study aimed to determine the ability of novel nomograms based onto readily-available clinical parameters, like those related to benign prostatic obstruction (BPO), in predicting the outcome of first prostate biopsy (PBx). To do so, we analyzed our Internal Review Board-approved prospecti...

Full description

Bibliographic Details
Main Authors: Luigi Cormio, Luca Cindolo, Francesco Troiano, Michele Marchioni, Giuseppe Di Fino, Vito Mancini, Ugo Falagario, Oscar Selvaggio, Francesca Sanguedolce, Francesca Fortunato, Luigi Schips, Giuseppe Carrieri
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Oncology
Subjects:
prostate biopsy
prostate cancer
nomogram
lower urinary tract symptoms
prostate volume
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00438/full

Similar Items

Similar Items